6MK
MERCK CO. DL,01
Stock XETRA – Stock Market Prices, News & Analysis
Entreprise américaine spécialisée dans la recherche, le développement et la commercialisation de produits pharmaceutiques et biologiques.
MERCK CO. DL,01
6MK
Entreprise américaine spécialisée dans la recherche, le développement et la commercialisation de produits pharmaceutiques et biologiques.
Price history of MERCK CO. DL,01
Price history of MERCK CO. DL,01
Performance & Momentum
Strategic Analysis
MERCK CO. DL,01 • 2026
Merck is a major healthcare player with an integrated model combining research, development and the commercialization of pharmaceutical and biologic products, including vaccines. Its differentiation is based on strong medical innovation capabilities and diversification across therapeutic segments with high growth potential.
Strengths
- Diversified portfolio combining prescription medicines, biologics and vaccines
- Sustained R&D investment enabling a robust pipeline
- Strong position in the United States with global visibility across pharmaceutical markets
Weaknesses
- Exposure to regulatory risks and pressure on drug pricing
- Dependence on certain key products that may face patent expirations
Momentum
The displayed momentum reflects positive dynamics supported by steady performance across several time horizons. This trend supports a strategic hold stance, anticipating a consolidation of growth driven by product innovation and recent launches.
Similar stocks to MERCK CO. DL,01
Take control
of your investments
Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.
- Real-time multi-portfolio tracking
- AI analysis of your positions
- Counter your cognitive biases
